Metastatic Sarcoma
Showing 1 - 25 of >10,000
Advanced Sarcoma, Metastatic Sarcoma, Soft Tissue Sarcoma Trial (YH001, Envafolimab, Doxorubicin)
Recruiting
- Advanced Sarcoma
- +2 more
- YH001
- +2 more
-
Santa Monica, CaliforniaSarcoma Oncology Center
Dec 5, 2022
Sarcoma Trial in Guangzhou (Fluzoparib+ Dalpiciclib)
Recruiting
- Sarcoma
- Fluzoparib+ Dalpiciclib
-
Guangzhou, Guangdong, ChinaCancer Center of Sun-Yat Sen University (CCSYSU)
Jul 11, 2023
Sarcoma, Sarcoma Metastatic Trial in Ann Arbor (Olaparib, Trabectedin)
Active, not recruiting
- Sarcoma
- Sarcoma Metastatic
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Dec 20, 2022
Soft Tissue Sarcoma Trial in France (SBRT + MEDI5752)
Not yet recruiting
- Soft Tissue Sarcoma
- SBRT + MEDI5752
-
Bordeaux, France
- +4 more
Apr 7, 2023
Metastatic Sarcoma, Sarcoma Trial in Seattle (Assessment, Questionnaire Administration, Interview)
Not yet recruiting
- Metastatic Sarcoma
- Sarcoma
- Assessment
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Apr 27, 2023
Sarcoma, Soft Tissue Trial in Orange (Pembrolizumab, Stereotactic body radiation therapy)
Recruiting
- Sarcoma, Soft Tissue
- Pembrolizumab
- Stereotactic body radiation therapy
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Aug 9, 2022
Advanced and/or Metastatic Sarcoma Trial in Houston (Durvalumab, Tremelimumab)
Active, not recruiting
- Advanced and/or Metastatic Sarcoma
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 7, 2022
Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone Trial in Shanghai (Camrelizumab and fluzoparib with concurrent stereotactic body
Recruiting
- Sarcoma
- +2 more
- Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT)
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University, School of Medici
Oct 3, 2023
Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance
Not yet recruiting
- Metastatic Leiomyosarcoma
- +5 more
- Computed Tomography
- +3 more
- (no location specified)
Feb 2, 2023
Study of Exosomes in Monitoring Patients With Sarcoma (EXOSARC)
Recruiting
- Sarcoma
- Blood samples
-
Besançon, France
- +2 more
Mar 24, 2022
Metastatic Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma Trial in Hannover (Durvalumab and Tremelimumab,
Completed
- Metastatic Adult Soft Tissue Sarcoma
- Recurrent Adult Soft Tissue Sarcoma
- Durvalumab and Tremelimumab
- Doxorubicin
-
Hannover, GermanyMedizinische Hochschule Hannover
Jan 18, 2023
Soft Tissue Sarcoma Trial (pembrolizumab, pazopanib)
Not yet recruiting
- Soft Tissue Sarcoma
- pembrolizumab, pazopanib
- (no location specified)
Dec 26, 2022
Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin
Active, not recruiting
- Advanced Soft Tissue Sarcoma
- +26 more
- Doxorubicin Hydrochloride
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jan 6, 2023
Clear Cell Sarcoma Trial in El Segundo, Houston (AMG 337)
Terminated
- Clear Cell Sarcoma
- AMG 337
-
El Segundo, California
- +1 more
Dec 9, 2022
Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle
Recruiting
- Metastatic Leiomyosarcoma
- +17 more
- Itacitinib
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 13, 2022
Metastatic Soft-tissue Sarcoma Trial in United States (Cabozantinib, Nivolumab, Ipilimumab)
Recruiting
- Metastatic Soft-tissue Sarcoma
- Cabozantinib
- +2 more
-
Stanford, California
- +3 more
Jan 10, 2023
Sarcoma, Epithelioid Sarcoma, Cutaneous Angiosarcoma Trial in Stanford, New York (Talimogene Laherparepvec (T-VEC),
Recruiting
- Sarcoma
- +2 more
- Talimogene Laherparepvec (T-VEC)
- Pembrolizumab
-
Stanford, California
- +1 more
Feb 2, 2023
Soft Tissue Sarcoma Trial in New York (Tigilanol Tiglate)
Not yet recruiting
- Soft Tissue Sarcoma
- Tigilanol Tiglate
-
New York, New YorkMemorial Sloan Kettering Cancer Centre
Mar 2, 2023
Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer
Not yet recruiting
- Locally Advanced Alveolar Soft Part Sarcoma
- +9 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 10, 2023
Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in Toulouse (Doxorubicin, Cyclophosphamide)
Recruiting
- Advanced Soft-tissue Sarcoma
- Metastatic Soft-tissue Sarcoma
-
Toulouse, FranceInstitut Claudius Reagaud-IUCT Oncopôle
Oct 6, 2022
Metastatic Bone Sarcoma, Metastatic Malignant Tumor in the Lung, Metastatic Soft Tissue Sarcoma Trial in Buffalo (Cisplatin,
Recruiting
- Metastatic Bone Sarcoma
- +5 more
- Cisplatin
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 24, 2023
Osteosarcoma Metastatic, Ewing's Sarcoma Metastatic Trial in Miami (Chemotherapy (gemcitabine & docetaxel) plus BIO-11006)
Active, not recruiting
- Osteosarcoma Metastatic
- Ewing's Sarcoma Metastatic
- Chemotherapy (gemcitabine & docetaxel) plus BIO-11006
-
Miami, FloridaNicklaus Children's Hospital
Nov 8, 2022